Mylan Will Acquire Pfizer Technology | Chemical & Engineering News
Volume 89 Issue 46 | p. 17 | Concentrates
Issue Date: November 14, 2011

Mylan Will Acquire Pfizer Technology

Department: Business
Keywords: generics, asthma, drug delivery

Mylan will acquire the rights to develop Pfizer’s generic equivalent to GlaxoSmithKline’s Advair Diskus and Seretide Diskus inhaler-based asthma drugs. Mylan will pay Pfizer $17.5 million plus additional payments contingent on regulatory and commercial success. In connection with the deal, Mylan will hire select employees from the former Pfizer respiratory inhalation development team based in Sandwich, England, where Mylan will set up a respiratory development division. Mylan says the deal expands its focus on difficult-to-produce, limited-competition products.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment